CJC-1295 (with DAC)
The long-acting version of CJC-1295. One injection lasts about a week because it grabs onto a blood protein (albumin). Instead of a single sharp pulse, it raises your GH/IGF-1 baseline for days; convenient, but less "natural" than the No-DAC pulse.
Typical dose
2 mg/week
100u (or 50u ×2), Once weekly (or split 2×/wk)
Cycle
8–12 weeks on / 4 weeks off
Timing
Any time of day (long half-life makes t…
Where
SubQ, abdomen
Standard
Weeks 1–2
50u1 mg · Once weekly
Start at the low end; the long half-life means levels build over the first 1–2 weeks.
Weeks 3–12
100u (or 50u ×2)2 mg/week · Once weekly (or split 2×/wk)
Standard. Splitting into 2 doses/week smooths levels and side effects.
Off
4 weeks
Let IGF-1 normalize before re-cycling.
Units column is for 2 mg/mL.
Cycle & timing
Cycle: 8–12 weeks on / 4 weeks off.
Timing: Any time of day (long half-life makes timing far less critical than No-DAC). Pair with a GHRP if a stronger pulse is wanted.
Where: SubQ, abdomen. Rotate.
What to expect
Sleep, recovery, and body-composition gains over 8–12 wks with weekly dosing; sustained IGF-1; monitor it.
How much to buy
For 12-wk @ 2 mg/week:
12
× 2mg vials
Men & women
Men: Men convert GH to IGF-1 more efficiently and more often overshoot the age ceiling (a higher malignancy signal), aim mid-normal for age, don't chase the top.
Women: Women make ~3× the GH of men yet have similar IGF-1, they're less responsive, so often need a higher dose to move IGF-1. Oral estrogen blunts IGF-1 further (read it as running low); a skin patch/gel is more predictable.